Join now

Already a member? Sign in

Welcome to Inspire!

What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.

Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.

How - Joining Inspire is completely free and usually takes less than a minute. Join now!

corner corner corner

libbyshope's discussions

PI3K Pathway: A Potential Ovarian Cancer Therapeutic Target?

libbyshope
  • By libbyshope · Posted November 20, 2009
  • In Ovarian Cancer National Alliance · 3 replies
  • I posted an article today, entitled "PI3K Pathway: A Potential Ovarian Cancer Therapeutic Target?" The article addresses two recent medical studies (an in vitro study & a Phase I clinical study) that ...

Nationwide Registry to "Match" Study Volunteers With Researchers

libbyshope
  • By libbyshope · Posted November 12, 2009
  • In Ovarian Cancer National Alliance · 6 replies
  • Individuals who want to participate in research studies now can connect online with researchers nationwide through the first disease-neutral, volunteer recruitment registry. ResearchMatch.org is a not-for-profit ...

FDA-Approved Drug Dasatinib (Sprycel) Significantly Inhibits OVCA Growth

libbyshope
  • By libbyshope · Posted November 11, 2009
  • In Ovarian Cancer National Alliance · 15 replies
  • The drug dasatinib (Sprycel®), approved for use by the U.S. Food and Drug Administration in patients with specific types of leukemia, significantly inhibited the growth and invasiveness of ovarian cancer ...

EC145 Produces Significant Anti-Tumor Activity In Advanced OVCA Patients

libbyshope
  • By libbyshope · Posted October 22, 2009
  • In Ovarian Cancer National Alliance · 6 replies
  • Endocyte, Inc., a cancer drug discovery and development company, presented data from a Phase IIa clinical trial for EC145, currently in development as a potential treatment for advanced ovarian cancer ...

Targeted Gene Therapies Use Diphtheria Toxin To Fight Ovarian Cancer

libbyshope
  • By libbyshope · Posted August 11, 2009
  • In Ovarian Cancer National Alliance · 13 replies
  • I read a posting yesterday under "clinical trials" regarding the use of nanoparticles to fight ovarian cancer. The post contained a cross link to the MIT-Lankenau Institute research work. FYI, I published ...

You